Codes / ICD10CM / T48.203A

T48.203A Poisoning by unspecified drugs acting on muscles, assault, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by unspecified drugs acting on muscles, assault, initial encounter

Summary

This condition involves poisoning by unspecified drugs acting on muscles due to assault, with the encounter classified as initial. It includes clinical effects resulting from exposure to these medications, where the specific agent is not identified and the event is attributed to intentional harm by another party.

Causes

Exposure to muscle-acting drugs in this context results from intentional administration or forced ingestion by another individual. The specific drug is not identified, but the event is linked to assault. Common scenarios include forced medication, tampering, or deliberate poisoning by a third party.

Risk Factors

  • Proximity to individuals with access to muscle-acting drugs.
  • History of interpersonal violence or conflict.
  • Vulnerable populations (e.g., domestic abuse victims, institutional settings).
  • Lack of supervision or control over medication access.
  • Situations involving coercion or forced ingestion.

Symptoms

  • Muscle weakness or paralysis.
  • Respiratory depression or difficulty breathing.
  • Dizziness, confusion, or altered mental status.
  • Nausea, vomiting, or gastrointestinal distress.
  • Hypotension or cardiovascular instability.

Diagnosis

Clinical evaluation focuses on symptoms, medication history, and assault documentation. Laboratory tests may assess drug levels or metabolites, though the specific agent remains unspecified. Forensic or legal documentation may be required to confirm the assault context.

Treatment Options

Management includes stabilizing the patient, addressing symptoms (e.g., respiratory support, cardiovascular monitoring), and providing antidotes if available. Decontamination (e.g., activated charcoal) may be considered based on timing and drug properties. Psychological support and safety planning are critical.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timely intervention, and underlying health. Follow-up involves monitoring for delayed effects, assessing for complications, and addressing psychological or safety concerns. Long-term care may be needed for persistent symptoms or trauma.

Complications

  • Respiratory failure requiring mechanical ventilation.
  • Prolonged muscle weakness or paralysis.
  • Cardiovascular instability (e.g., hypotension, arrhythmias).
  • Neurological sequelae (e.g., confusion, cognitive impairment).
  • Psychological trauma or PTSD related to the assault.

Lifestyle & Prevention

  • Secure storage of medications to prevent unauthorized access.
  • Education on recognizing and reporting suspected poisoning.
  • Support for at-risk individuals (e.g., domestic violence resources).
  • Legal or protective measures for those in high-risk environments.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning (e.g., difficulty breathing, muscle weakness, altered mental status) occur, especially if assault is suspected. Contact emergency services or a healthcare provider promptly.

Tips for Medical Coders

Document the assault context clearly, including any legal or forensic details, to support the use of this code. Ensure the encounter is classified as "initial" and that the drug agent remains unspecified. Verify that the poisoning is directly linked to the assault event for accurate coding.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T48.203A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.